These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2686548)

  • 1. Evaluation of cilofungin (LY121019) for treatment of experimental Candida albicans endocarditis in rabbits.
    Padula A; Chambers HF
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1822-3. PubMed ID: 2686548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative efficacies of cilofungin (Ly121019) and amphotericin B against disseminated Candida albicans infection in normal and granulocytopenic mice.
    Khardori N; Nguyen H; Stephens LC; Kalvakuntla L; Rosenbaum B; Bodey GP
    Antimicrob Agents Chemother; 1993 Apr; 37(4):729-36. PubMed ID: 8494367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergy between cilofungin and amphotericin B in a murine model of candidiasis.
    Hanson LH; Perlman AM; Clemons KV; Stevens DA
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1334-7. PubMed ID: 1929290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of cilofungin and amphotericin B on experimental murine candidiasis.
    Morrison CJ; Stevens DA
    Antimicrob Agents Chemother; 1990 May; 34(5):746-50. PubMed ID: 2193617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of cilofungin therapy administered by continuous intravenous infusion for experimental disseminated candidiasis in rabbits.
    Rouse MS; Tallan BM; Steckelberg JM; Henry NK; Wilson WR
    Antimicrob Agents Chemother; 1992 Jan; 36(1):56-8. PubMed ID: 1590700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis due to Candida albicans.
    Louie A; Liu W; Miller DA; Sucke AC; Liu QF; Drusano GL; Mayers M; Miller MH
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2831-40. PubMed ID: 10582868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifungal effects of the nonlinear pharmacokinetics of cilofungin, a 1,3-beta-glucan synthetase inhibitor, during continuous and intermittent intravenous infusions in treatment of experimental disseminated candidiasis.
    Walsh TJ; Lee JW; Kelly P; Bacher J; Lecciones J; Thomas V; Lyman C; Coleman D; Gordee R; Pizzo PA
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1321-8. PubMed ID: 1929288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal activity of caspofungin in experimental infective endocarditis caused by Candida albicans.
    Victorio GB; Bourdon LMB; Benavides LG; Huerta-Olvera SG; Plascencia A; Villanueva J; Martinez-Lopez E; Hernández-Cañaveral II
    Mem Inst Oswaldo Cruz; 2017 May; 112(5):370-375. PubMed ID: 28443984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro activity of cilofungin (LY121019) in comparison with amphotericin B.
    Meunier F; Lambert C; Van der Auwera P
    J Antimicrob Chemother; 1989 Sep; 24(3):325-31. PubMed ID: 2681118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of caspofungin to treat brain abscesses secondary to Candida albicans prosthetic valve endocarditis.
    Prabhu RM; Orenstein R
    Clin Infect Dis; 2004 Oct; 39(8):1253-4. PubMed ID: 15486856
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of fluconazole and amphotericin B for treatment of experimental Candida albicans endocarditis in rabbits.
    Chemlal K; Saint-Julien L; Joly V; Farinotti R; Seta N; Yeni P; Carbon C
    Antimicrob Agents Chemother; 1996 Jan; 40(1):263-6. PubMed ID: 8787921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinal toxicity and in vitro efficacy study of cilofungin (LY121019).
    Shahsavari M; Peyman GA; Niesman MR
    Ophthalmic Surg; 1990 Oct; 21(10):726-8. PubMed ID: 2250858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy of cilofungin, fluconazole and amphotericin B in the treatment of systemic Candida albicans infection in the neutropenic mouse.
    Bannatyne RM; Cheng PC; Fong IW
    Infection; 1992; 20(3):168-70. PubMed ID: 1644494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of experimental disseminated candidiasis with cilofungin.
    Perfect JR; Hobbs MM; Wright KA; Durack DT
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1811-2. PubMed ID: 2589848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of cilofungin alone and in combination with amphotericin B in a murine model of disseminated aspergillosis.
    Denning DW; Stevens DA
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1329-33. PubMed ID: 1929289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cure of Candida glabrata native tricuspid valve endocarditis by continuous infusion of conventional amphotericin B in a patient with nephrotic syndrome.
    Williams J; Lye DC
    Int J Antimicrob Agents; 2007 Aug; 30(2):192-3. PubMed ID: 17555946
    [No Abstract]   [Full Text] [Related]  

  • 17. Endocarditis caused by Candida dubliniensis.
    Garcia J; Soch K; Matthew E; Surani S; Horseman MA
    Am J Med Sci; 2013 Sep; 346(3):237-9. PubMed ID: 23974269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cilofungin (LY121019), a fungal cell wall synthesis inhibitor, on interactions of Candida albicans with human neutrophils.
    Meshulam T; Levitz SM; Diamond RD; Sugar AM
    J Antimicrob Chemother; 1989 Nov; 24(5):741-5. PubMed ID: 2689424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental Candida albicans endocarditis: characterization of the disease and response to therapy.
    Sande MA; Bowman CR; Calderone RA
    Infect Immun; 1977 Jul; 17(1):140-7. PubMed ID: 328393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of fluconazole and amphotericin B for treatment of experimental Candida endocarditis caused by non-C. albicans strains.
    Witt MD; Imhoff T; Li C; Bayer AS
    Antimicrob Agents Chemother; 1993 Sep; 37(9):2030-2. PubMed ID: 8239628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.